NY A09407

Prohibits insurers, health care plans, and managed care providers from requiring prior authorization for cancer treatments that meet Category 1 or Category 2-A of the National Comprehensive Cancer Network's Categories of Evidence and Consensus

Allows insurers and health plans to require healthcare providers to certify that the oncology patient's treatment meets National Comprehensive Cancer Network Guidelines

Preserves insurers' ability to deny claims after the fact if services are subsequently determined not medically necessary

Applies to multiple types of coverage including commercial insurance, nonprofit health corporations, HMOs, and Medicaid managed care plans

Takes effect 180 days after becoming law